Evaluating the Ups and Downs of Rockwell Medical Inc’s (RMTI) Stock

In the past week, RMTI stock has gone up by 16.55%, with a monthly gain of 28.57% and a quarterly plunge of -11.96%. The volatility ratio for the week is 13.94%, and the volatility levels for the last 30 days are 10.07% for Rockwell Medical Inc The simple moving average for the past 20 days is 9.91% for RMTI’s stock, with a -30.66% simple moving average for the past 200 days.

Is It Worth Investing in Rockwell Medical Inc (NASDAQ: RMTI) Right Now?

Additionally, the 36-month beta value for RMTI is 1.17. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 1 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for RMTI is 26.49M and currently, short sellers hold a 2.37% ratio of that float. The average trading volume of RMTI on March 25, 2024 was 242.17K shares.

RMTI) stock’s latest price update

Rockwell Medical Inc (NASDAQ: RMTI)’s stock price has gone decline by -5.26 in comparison to its previous close of 1.71, however, the company has experienced a 16.55% increase in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-21 that Rockwell Medical (RMTI) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to loss of $0.20 per share a year ago.

Analysts’ Opinion of RMTI

Many brokerage firms have already submitted their reports for RMTI stocks, with Piper Jaffray repeating the rating for RMTI by listing it as a “Overweight.” The predicted price for RMTI in the upcoming period, according to Piper Jaffray is $10 based on the research report published on June 24, 2019 of the previous year 2019.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see RMTI reach a price target of $11. The rating they have provided for RMTI stocks is “Buy” according to the report published on May 13th, 2019.

RMTI Trading at 15.32% from the 50-Day Moving Average

After a stumble in the market that brought RMTI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.04% of loss for the given period.

Volatility was left at 10.07%, however, over the last 30 days, the volatility rate increased by 13.94%, as shares surge +18.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.19% upper at present.

During the last 5 trading sessions, RMTI rose by +16.55%, which changed the moving average for the period of 200-days by -61.34% in comparison to the 20-day moving average, which settled at $1.4865. In addition, Rockwell Medical Inc saw -14.29% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for RMTI

Current profitability levels for the company are sitting at:

  • -0.08 for the present operating margin
  • 0.1 for the gross margin

The net margin for Rockwell Medical Inc stands at -0.11. The total capital return value is set at -0.19. Equity return is now at value -47.68, with -17.08 for asset returns.

Based on Rockwell Medical Inc (RMTI), the company’s capital structure generated 0.33 points at debt to capital in total, while cash flow to debt ratio is standing at -0.9. The debt to equity ratio resting at 0.49. The interest coverage ratio of the stock is -4.51.

Currently, EBITDA for the company is -5.23 million with net debt to EBITDA at -0.78. When we switch over and look at the enterprise to sales, we see a ratio of 0.62. The receivables turnover for the company is 7.67for trailing twelve months and the total asset turnover is 1.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.73.

Conclusion

In conclusion, Rockwell Medical Inc (RMTI) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts